Clinical trials
Phase 3 Thrombocytopenia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2018 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 4 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shandong University | 3 |
| Eisai Inc. | 2 |
| Beijing Northland Biotech. Co., Ltd. | 1 |
| Chinese SLE Treatment And Research Group | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| GlaxoSmithKline | 1 |
| Novartis Pharmaceuticals | 1 |
| Peking Union Medical College | 1 |
| Shenzhen Second People's Hospital | 1 |
| Sobi, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 15 |
| Purpura, Thrombocytopenic, Idiopathic | 6 |
| Purpura | 4 |
| Hematologic Diseases | 2 |
| Autoimmune Diseases | 1 |
| Blood Platelet Disorders | 1 |
| Cytopenia | 1 |
| Hemorrhage | 1 |
| Hemorrhagic Disorders | 1 |
| Immune System Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.